Inno-206
AIDS-related Immunoblastic Large Cell Lymphoma
AIDS Malignancy ConsortiumPhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the AIDS-related Immunoblastic Large Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS AIDS Malignancy Consortium | Phase 2 | B |
Cyclophosphamide AIDS Malignancy Consortium | Phase 2 | B |
ETOPOSIDE AIDS Malignancy Consortium | Phase 2 | B |
VINCRISTINE SULFATE AIDS Malignancy Consortium | Phase 2 | B |
Procarbazine AIDS Malignancy Consortium | Phase 2 | B |
View all 22 →
Same molecule, other indications
Inno-206 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →